Penzkofer, Lea; Groeger, Lisa-Katharina; Hoppe-Lotichius, Maria et al.
Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single CenterCANCERS. Bd. 15. H. 3. 2023
Haber, Philipp K.; Castet, Florian; Torres-Martin, Miguel et al.
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular CarcinomaGASTROENTEROLOGY. Bd. 164. H. 1. 2023
Tomalla, Vanessa; Schmeisser, Michael J.; Weinmann-Menke, Julia
Mouse models, antibodies, and neuroimaging: Current knowledge and future perspectives in neuropsychiatric systemic lupus erythematosus (NPSLE)FRONTIERS IN PSYCHIATRY. Bd. 14. 2023
Schattenberg, Joern M.; Balp, Maria-Magdalena; Reinhart, Brenda et al.
NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settingsSCIENTIFIC REPORTS. Bd. 13. H. 1. 2023
Wu, Linda; Fulgenzi, Claudia A. M.; D'Alessio, Antonio et al.
Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic biomarkers in unresectable hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (atezo-bev).JOURNAL OF CLINICAL ONCOLOGY. Bd. 41. 2023 S. 504-504
Janjigian, Yelena Y.; Shitara, Kohei; Moehler, Markus H. et al.
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 3-year follow-up from CheckMate 649JOURNAL OF CLINICAL ONCOLOGY. Bd. 41. H. 16. 2023
Janjigian, Yelena Y.; Shitara, Kohei; Moehler, Markus H. et al.
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 3-year follow-up from CheckMate 649.JOURNAL OF CLINICAL ONCOLOGY. Bd. 41. 2023 S. 291-291
Janjigian, Yelena Y.; Shitara, Kohei; Ajani, Jaffer et al.
Nivolumab plus ipilimumab vs chemotherapy as first-line treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma: CheckMate 649 biomarker analysesCANCER RESEARCH. Bd. 83. H. 8. 2023
Marinoska, Tatjana; Moeckel, Tamara; Triantafyllias, Konstantinos et al.
NMDA Receptors in Health and Diseases: New Roles and Signaling Pathways-Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Autoantibodies as Potential Biomarkers of Fatigue in Patients with Rheumatic DiseasesINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 24. H. 4. 2023
Schattenberg, Joern; Frias, Juan P.; Neff, Guy et al.
Non-invasive tests of liver injury, inflammation and fibrosis are improved by efruxifermin and correlate with histological improvements in F2-F3 NASH patients: secondary analysis of Ph2b HARMONY studyJOURNAL OF HEPATOLOGY. Bd. 78. 2023 S. S808-S809